In a significant move to combat rising cancer cases in India, Union Minister of State for Health, Family Welfare, and Ayush (Independent Charge) Prataprao Jadhav has announced a groundbreaking vaccine targeting cancers that predominantly affect women. The vaccine, currently in its final research phase, is expected to be available within five to six months. It will be administered to girls aged 9 to 16, focusing on preventing breast, oral, and cervical cancers.
"The research on a vaccine for cancers that affect women is nearly complete, and trials are underway. It will be available in five to six months", Jadhav said.
This initiative is part of the Central government’s multi-pronged strategy to address the increasing incidence of cancer, which includes screening programs for women over 30 and the establishment of daycare cancer centres for early detection.
In addition, customs duties on cancer medications have been waived to make treatment more accessible. For a holistic approach, traditional medicine has also been integrated into existing hospital systems, with 12,500 Ayush facilities currently operating nationwide.
Cancer vaccines bolster the immune system to selectively attack malignant cells. Unlike conventional vaccines that use weakened pathogens, they target specific proteins on cancer cells. Preventive versions aim to stop cancer before it starts, while therapeutic ones focus on existing tumours. This immunotherapeutic approach primes the body to recognize and eliminate cancer cells effectively.
With the impending release of this vaccine, healthcare professionals are advised to stay updated on clinical guidelines and recommended protocols to ensure the best possible patient outcomes for optimal care.
